Pharma left behind in US reform stakes
According to the International Herald Tribune, the pharmaceutical and biotechnology industries in the US may regret their traditional support for the Republicans as the US patent reform moves gather pace in Congress. With the Democrats now in…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.